George W. Buchman
Corporate Officer/Principal presso Catalent Maryland, Inc.
Profilo
George W.
Buchman is currently the VP-Preclinical Services & Process Development at Catalent Maryland, Inc. Previously, he worked as the Chief Scientific Officer & Vice President at Chesapeake PERL, Inc. He obtained his undergraduate degree from Albright College and the University of Maryland.
Posizioni attive di George W. Buchman
| Società | Posizione | Inizio |
|---|---|---|
Catalent Maryland, Inc.
 Catalent Maryland, Inc. BiotechnologyHealth Technology Catalent Maryland, Inc. engages in the manufactures of biopharmaceuticals products such as viral vectors, vaccines, and proteins and oncolytic viruses. It offers process development, GMP manufacturing, fill and finish, analytical development, master and working cell and virus banks, quality systems, and stabilities studies services. The company was founded by Marco A. Chacon in 1990 and is headquartered in Baltimore, MD. | Corporate Officer/Principal | 01/01/2014 |
Precedenti posizioni note di George W. Buchman
| Società | Posizione | Fine |
|---|---|---|
Chesapeake PERL, Inc.
 Chesapeake PERL, Inc. BiotechnologyHealth Technology Chesapeake PERL, Inc. operates as a biotechnology company which develops and produces proteins. Its proprietary technology - PERLXPRess, which uses insect larvae allows manufacturing without expensive process development for scale-up. The firm also produces humanized glycoproteins and human therapeutics, including kinases, viral antigens and antibodies. The company was founded by Terry E. Chase, Minh Q. Pham and William E. Bentley in 1998 and is headquartered in Savage, MD. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di George W. Buchman
| Albright College | Undergraduate Degree |
| University of Maryland | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Chesapeake PERL, Inc.
Chesapeake PERL, Inc. BiotechnologyHealth Technology Chesapeake PERL, Inc. operates as a biotechnology company which develops and produces proteins. Its proprietary technology - PERLXPRess, which uses insect larvae allows manufacturing without expensive process development for scale-up. The firm also produces humanized glycoproteins and human therapeutics, including kinases, viral antigens and antibodies. The company was founded by Terry E. Chase, Minh Q. Pham and William E. Bentley in 1998 and is headquartered in Savage, MD. | Health Technology |
Catalent Maryland, Inc.
Catalent Maryland, Inc. BiotechnologyHealth Technology Catalent Maryland, Inc. engages in the manufactures of biopharmaceuticals products such as viral vectors, vaccines, and proteins and oncolytic viruses. It offers process development, GMP manufacturing, fill and finish, analytical development, master and working cell and virus banks, quality systems, and stabilities studies services. The company was founded by Marco A. Chacon in 1990 and is headquartered in Baltimore, MD. | Health Technology |
- Borsa valori
- Insiders
- George W. Buchman
